Associated Papers
Clinical, Neuroimaging, and Genetic Markers Associated with Cognitive and Functional Outcomes After Traumatic Brain Injury.
Duve K et al.
Journal of Clinical Medicine, 2025
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions-A Comprehensive Review.
Lewoń-Mrozek D et al.
International Journal of Molecular Sciences, 2024
The Molecular Bases of Anti-Oxidative and Anti-Inflammatory Properties of Paraoxonase 1.
Jakubowski H
Antioxidants (basel, Switzerland), 2024
A Case-Control Study Supports Genetic Contribution of the PON Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease.
Van Dijck E et al.
Antioxidants (basel, Switzerland), 2024
[Association of the -c.108C>T and c.192Q>R polymorphisms of the PON1 gene with preeclampsia among Chinese women].
Zhang X et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2024
Association between paraoxonase 1 -108C/T polymorphism and coronary heart disease: an updated meta-analysis.
Liao J et al.
Frontiers in Cardiovascular Medicine, 2024
The Regulatory Variant -108C/T in the Promoter of Paraoxonase 1 (PON1) Gene has a More Important Role in Regulating PON1 Activity Compared to rs3735590 in 3'-UTR in Patients with Coronary Artery Disease.
Zargari M et al.
Advanced Biomedical Research, 2024
Proteomic Exploration of Paraoxonase 1 Function in Health and Disease.
Jakubowski H
International Journal of Molecular Sciences, 2023
Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease.
Petrič B et al.
Antioxidants (basel, Switzerland), 2023
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis.
Arida A et al.
Scientific Reports, 2022
Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development.
Vavlukis M et al.
Frontiers in Genetics, 2022
VARIANTS OF IL1 (C3954T, RS1143634), PON1 (C108T, RS705379) GENES AS PROGNOSTIC MARKERS OF OSTEOMYELITIS RISK AND ITS COMPLICATIONS.
Kolov G et al.
Georgian Medical News, 2021
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.
Diels S et al.
Clinical Epigenetics, 2021
Arylesterase activity of paraoxonase 1 (PON1) on HDL3 and HDL2: Relationship with Q192R, C-108T, and L55M polymorphisms.
Valencia C SY et al.
Biochemistry and Biophysics Reports, 2021
An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report).
Panebianco M et al.
Current Oncology (toronto, Ont.), 2021
Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus.
Zhou M et al.
Pediatric Research, 2021
The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.
Wysocka A et al.
International Journal of Molecular Sciences, 2021
Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.
Piras IS et al.
Antioxidants (basel, Switzerland), 2021
Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach.
Roberto M et al.
Pharmaceuticals (basel, Switzerland), 2021
A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.
Petrič B et al.
Omics : a Journal of Integrative Biology, 2021
PON1 Q192R is associated with high platelet reactivity with clopidogrel in patients undergoing elective neurointervention: A prospective single-center cohort study.
Tanaka K et al.
Plos One, 2021
Associations between nine candidate genetic polymorphisms with coronary heart disease : A meta-analysis.
Li Q et al.
Herz, 2020
Association between pesticide exposure and paraoxonase-1 (PON1) polymorphisms, and neurobehavioural outcomes in children: a systematic review.
Banhela N et al.
Systematic Reviews, 2020
Bayesian meta-analysis of inter-phenotypic differences in human serum paraoxonase-1 activity for chemical risk assessment.
Darney K et al.
Environment International, 2020
Association between Single Nucleotide Polymorphisms and Glioma Risk: A Systematic Literature Review.
Tavares CB et al.
Cancer Investigation, 2020
Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.
Shokri Y et al.
Diabetes Research and Clinical Practice, 2020
Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
Zhou M et al.
Journal of Diabetes Research, 2020
Association of Paraoxonase 1 Gene Polymorphisms and Polycystic Ovarian Syndrome Susceptibility: A Systematic Review and Meta-Analysis.
Jiang X et al.
Gynecologic and Obstetric Investigation, 2020
Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients.
Marinko T et al.
Disease Markers, 2020
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.
Hashemi MM et al.
Diabetes Research and Clinical Practice, 2019
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Wysocka A et al.
Journal of Clinical Medicine, 2019
Homocysteine Modification in Protein Structure/Function and Human Disease.
Jakubowski H
Physiological Reviews, 2019
Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.
Liao D et al.
Journal of Endocrinological Investigation, 2018
PON1 gene polymorphisms in patients with chronic obstructive pulmonary disease.
Grdić Rajković M et al.
Journal of Clinical Pathology, 2018
A Meta-Prediction of Methylenetetrahydrofolate-Reductase Polymorphisms and Air Pollution Increased the Risk of Ischemic Heart Diseases Worldwide.
Chen ZF et al.
International Journal of Environmental Research and Public Health, 2018
Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants.
Dardiotis E et al.
Environment International, 2018
PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.
Dadachanji R et al.
Gene, 2018
Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.
Emami A et al.
Interventional Medicine & Applied Science, 2018
Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics.
Pavăl D et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology, 2018
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
Tajbakhsh A et al.
Clinical Biochemistry, 2017
Association between promoter polymorphism (-108C>T) of paraoxonase1 gene and it's paraoxonase activity in patients with Type2 diabetes in northern Iran.
Shakeri R et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2017
A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease.
Nie Y et al.
Journal of Geriatric Psychiatry and Neurology, 2017
Urinary organophosphate insecticide metabolite concentrations during pregnancy and children's interpersonal, communication, repetitive, and stereotypic behaviors at 8 years of age: The home study.
Millenson ME et al.
Environmental Research, 2017
A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.
Morgan S et al.
Brain : a Journal of Neurology, 2017
CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.
Kaur G et al.
Journal of Genetics, 2017
Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology.
Strauss E et al.
International Journal of Cardiology, 2017
Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms.
Saeidi M et al.
The Open Biochemistry Journal, 2017
The association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome.
Gu HF et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2016
Activity and determinants of cholinesterases and paraoxonase-1 in blood of workers exposed to non-cholinesterase inhibiting pesticides.
Lozano-Paniagua D et al.
Chemico-biological Interactions, 2016
Genetic variation at Q192R and L55M polymorphisms in PON1.
Mitra S et al.
Environmental Toxicology and Pharmacology, 2016